{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:55:54Z","timestamp":1793832954946,"version":"4.6.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015086","name":"AOP Orphan Pharmaceuticals GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015086","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-05871-8","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:55:55Z","timestamp":1771246555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Attenuated hemodynamic response to adjunct vasopressin in obese septic shock patients: a physiological or dose-dependent effect?"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5198-5936","authenticated-orcid":false,"given":"Max","family":"Melchers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-4303","authenticated-orcid":false,"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6276-7192","authenticated-orcid":false,"given":"Arthur Raymond Hubert","family":"van Zanten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"6","key":"5871_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00134-019-05594-1","volume":"45","author":"M Schetz","year":"2019","unstructured":"Schetz M, De Jong A, Deane AM, Druml W, Hemelaar P, Pelosi P, et al. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019;45(6):757\u201369.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5871_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05540-2","volume":"29","author":"Q Lajoye","year":"2025","unstructured":"Lajoye Q, Orieux A, Boyer A, Prevel R, Jozwiak M. Vasopressin and its analogues in patients with septic shock: holy grail or unfulfilled promise? Crit Care. 2025;29(1):333.","journal-title":"Crit Care"},{"issue":"1","key":"5871_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01472-w","volume":"15","author":"M Melchers","year":"2025","unstructured":"Melchers M, de Smet V, Rooijakkers C, Huising J, Vermeulen W, K\u00f6kta\u015f BNN, et al. Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study. Ann Intensive Care. 2025;15(1):59.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"5871_CR4","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/cc12794","volume":"17","author":"P Wacharasint","year":"2013","unstructured":"Wacharasint P, Boyd JH, Russell JA, Walley KR. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013;17(3):R122.","journal-title":"Crit Care"},{"issue":"12","key":"5871_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1177\/10600280211007213","volume":"55","author":"CA Dubrawka","year":"2021","unstructured":"Dubrawka CA, Betthauser KD, Pope HE, Gibson GA. Effect of vasopressin dose on hemodynamic response in obese patients with septic shock: a retrospective observational study. Ann Pharmacother. 2021;55(12):1447\u201354.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"5871_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/1060028016656384","volume":"50","author":"EK Hodge","year":"2016","unstructured":"Hodge EK, Hughes DW, Attridge RL. Effect of body weight on hemodynamic response in patients receiving fixed-dose vasopressin for septic shock. Ann Pharmacother. 2016;50(10):816\u201323.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"5871_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/SHK.0000000000001086","volume":"50","author":"H Torbic","year":"2018","unstructured":"Torbic H, Sacha GL, Bauer SR, Lam SW. Body mass\u2019s impact on response to fixed-dose vasopressin in patients with septic shock. Shock. 2018;50(4):388\u201394.","journal-title":"Shock"},{"issue":"8","key":"5871_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.34067\/KID.0000000000000194","volume":"4","author":"JA Watts","year":"2023","unstructured":"Watts JA, Arroyo JP. Rethinking vasopressin: new insights into vasopressin signaling and its implications. Kidney360. 2023;4(8):1174\u201380.","journal-title":"Kidney360"},{"issue":"5","key":"5871_CR9","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1210\/en.2006-1315","volume":"148","author":"T Aoyagi","year":"2007","unstructured":"Aoyagi T, Birumachi J, Hiroyama M, Fujiwara Y, Sanbe A, Yamauchi J, et al. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology. 2007;148(5):2075\u201384.","journal-title":"Endocrinology"},{"issue":"4","key":"5871_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/joim.12649","volume":"282","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Velho G, Bouby N. Vasopressin and metabolic disorders: translation from experimental models to clinical use. J Intern Med. 2017;282(4):298\u2013309.","journal-title":"J Intern Med"},{"issue":"7","key":"5871_CR11","doi-asserted-by":"publisher","first-page":"E1065","DOI":"10.1210\/jc.2010-2981","volume":"96","author":"S Enh\u00f6rning","year":"2011","unstructured":"Enh\u00f6rning S, Struck J, Wirf\u00e4lt E, Hedblad B, Morgenthaler NG, Melander O. Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab. 2011;96(7):E1065\u201372.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-05871-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05871-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-05871-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:11:59Z","timestamp":1776150719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-05871-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5871"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-05871-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The primary study received a waiver from the Dutch \u2018Medical Research Involving Human Subjects Act\u2019 from the medical ethical committee of Wageningen University and Research on December 20, 2020. Informed consent was obtained from each subject or, when applicable, from a legal representative, next of kin, or proxy in accordance to local protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MM reported receiving honoraria for advisory board meetings, lectures, and travel expenses from AOP pharma. PP reported receiving honoraria for advisory board meetings, lectures, research, and travel expenses from AOP Pharma, AM-Pharma, EBI, 4Teen4, and Adrenomed. AvZ reported receiving honoraria for advisory board meetings, lectures, research, and travel expenses from AOP Pharma, Abbott, Baxter, Cardinal Health, Danone-Nutricia, DIM3, Dutch Medical Food, Fresenius Kabi, GE Healthcare, InBody, Mermaid, Rousselot, and Lyric.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}